Saying goodbye to biotechnology's booming "days of wine and roses," as well as the tricky "days of smoke and mirrors" that followed, industry leaders had better adopt a more realistic view of the present "days of our lives," when resources are tight and demands from partners are high. (BioWorld Today) Read More
